Riskpilot← Back to searchSign inGet full accessArcuatus AB
ABActiveOrg 5590493127Lidskjalfsvägen 4 BMedical specialists activities · NACE 8622Est. 20161 employees
Revenue 2025
SEK 2,8M
+17% vs 2024
EBITDA margin
61.5%
+30% vs 2024
Equity ratio
75.2%
Financial strength
Net profit 2025
SEK 1,2M
+23% vs 2024
| Revenue | SEK 2,8M | +17% |
| EBITDA | SEK 1,7M | +30% |
| Net profit | SEK 1,2M | +23% |
| Total assets | SEK 7,6M | +19% |
| Equity | SEK 5,7M | +18% |
| Employees | 1 | — |
Legal name
Arcuatus AB
Org number
5590493127
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
29 januari 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva läkarverksamhet, konsult- och utbildningsverksamhet inom medicin samt handel med konst, antikviteter, värdepapper, fast egendom och därmed förenlig verksamhet.
Address
Lidskjalfsvägen 4 B
Email
axelrhenman@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 641 | 1 217 | 1 902 | 2 388 | 2 790 |
| Staff expenses | — | −736 | −710 | −888 | −972 |
| EBITDA | 744 | 239 | 1 014 | 1 319 | 1 716 |
| Depreciation & amort. | −5 | −6 | −10 | −10 | −6 |
| EBIT | 739 | 233 | 1 004 | 1 309 | 1 710 |
| Net financials | — | 210 | 2 | 12 | 1 |
| Profit before tax | 739 | 1 072 | 756 | 1 236 | 1 516 |
| Tax | −156 | −188 | −160 | −264 | −323 |
| Net profit | 583 | 884 | 596 | 971 | 1 193 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 934 | 4 904 | 5 565 | 6 411 | 7 644 |
| Equity | 3 183 | 3 817 | 4 163 | 4 884 | 5 747 |
| Long-term debt | 3 | 3 | 0 | — | — |
| Short-term debt | 159 | 125 | 193 | 233 | 409 |
| Total debt | 162 | 129 | 193 | 233 | 409 |
EBITDA margin
61.5%
This company
15.8%
Market median
+289% vs market
20212025
Equity ratio
75.2%
This company
38.2%
Market median
+97% vs market
20212025
Return on equity
20.8%
This company
18.4%
Market median
+13% vs market
20212025
Net profit margin
42.8%
This company
8.1%
Market median
+428% vs market
20212025
Asset turnover
0.36×
This company
1.12×
Market median
-68% vs market
20212025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Arcuatus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Axel Henrik Rhenman | Chairman | 0 companies |
| Nina Annika Rhenman | Board of Directors | 0 companies |
| Karin Ann-Mari Rhenman | Deputy Board Member | 0 companies |